Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Holdings, widely known as LabCorp, has reached a new 52-week high, with its stock price soaring to $248.69. With a market ...

Supreme Court agrees to consider stopping class action lawsuit that accuses Labcorp Holdings unit of discrimination because ...

On January 6, 2025, the United States Court of Appeals for the Federal Circuit (“CAFC”) affirmed the decision of the Patent Trial and Appeal ...

Ravgen Inc. prevailed in a hearing at the Federal Circuit over Labcorp Inc., seemingly bringing a close to a long-running dispute over patents for non-invasive prenatal tests. Ravgen has won damages ...

Labcorp also purchased Legacy Health’s laboratory and announced in September that it planned to downsize that lab and shift ...

Highlights from the first day included updates from several firms about their China businesses and M&A strategies.

Shares of Labcorp Holdings Inc. LH rallied 1.19% to $237.30 Wednesday, on what proved to be an all-around positive trading ...

Former Executive Chairman and CEO of LabCorp, joins Advisory Board as the company enters its pre-commercialization phase "As a visionary leader who has made seminal contributions to healthcare, Dave's ...

Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Labcorp Holdings (NYSE:LH) from In-Line to Outperform. Analyst Price Forecast Suggests 15.09% Upside As of ...